Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
JHAA Stock Summary
In the News
CEF Weekly Review: Sell In May Worked This Time
We review CEF market valuation and performance through the first week of June and highlight recent market action. CEFs finished in a strong fashion, partly reversing the weakness over May. With a weak May behind us, we take a look at seasonality and whether "sell in May" works in CEFs.
JHAA: A 'Drier-Powder' Double-Digit Yield Opportunity For The Rest Of The Year
Nuveen Corporate Income 2023 Target Term is a Nuveen target term fund allocated mostly to BBB/BB-rated corporate bonds. JHAA is expected to terminate this December, which offers a potential opportunity given the fund continues to trade at a discount. Adding up all the fund's key performance drivers into December, we come up with a roughly 10% yield opportunity.
JHAA: Conservative ~5% Yield With This Target-Term CEF
JHAA is a target term corporate income fund due to terminate in 2023. I predict that it could provide a relatively safe ~5% yield at least for the next two years.
The Chemist's Quality Closed-End Fund Report: August 2020
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given.
Weekly Closed-End Fund Roundup: August 9, 2020
23 out of 23 CEF sectors positive on price and 23 out of 23 sectors positive on NAV last week. Commodities continue to rally, energy also puts in a strong performance.
Nuveen Announces Update to Closed-End Fund Portfolio Management Teams
Portfolio manager responsibilities for twelve closed-end funds have been updated. Michael Ainge, Anders Persson, Bernard Wong and Jenny Rhee are being removed as portfolio managers from several funds. Jake Fitzpatrick, Chris Williams and Kevin Lorenz are being added as portfolio managers to several funds. Portfolio manager changes by fund are detailed in the table below. There will be no impact on the investment approach, investment strategies or any of the fund’s investment objectives or policies.
How To Strengthen High-Yield Allocations With Term CEFs
The high-yield sector has proven relatively resilient this year owing to its long duration profile. However, with the bulk of credit spread widening now retraced, it makes sense to take some chips off the table and lighten up on risk in the sector.
Two Nuveen Target Term Closed-end Funds Approve Investment Policy and Name Changes
The Fund Board of the Nuveen High Income 2023 Target Term Fund (NYSE: JHAA) and Nuveen High Income November 2021 Target Term Fund (NYSE: JHB) has approved changes to each Fund’s name to "Nuveen Corporate Income 2023 Target Term Fund" and "Nuveen Corporate Income November 2021 Target Term Fund", respectively.
CEF Weekly Commentary: May 3, 2020
Markets on the week were little changed, but did end on a down note and some friction boiling up again on the trade front. We discuss the closed-end fund news o
LiveXLive Continues Partnership With iHeartMedia To Stream Elvis Duran's 'Stay At Home Ball' With An All-Star Roster Of 50+ Appearances & Performers Including Bebe Rexha, Kesha, Lewis Capaldi, Thomas Rhett Benefiting Project C.U.R.E
LiveXLive Media, Inc. (NASDAQ: LIVX) ("LiveXLive" or the "Company"), a global digital media company focused on live entertainment, announced today that it will stream Elvis Duran's 'Stay At Home Ball' featuring 50+ appearances and performances on Friday, April 24th from 8-11 p.m. ET/5-8 p.m. PT benefiting Project C.U.R.E. After the success of LiveXLive's 'Music Lives' 48-hour nonstop global music digital festival and its co-stream of Global Citizen and World Health Organization's "One World: Together At Home" special LiveXLive has become a must-stop for partners looking to live stream mini-festivals. The company continues the momentum by partnering with iHeartMedia and Elvis Duran to bring an all-star roster of performers to LiveXLive's streaming platform for fans across the globe.
JHAA Financial details
JHAA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 1.1 | 0.24 | 0.41 | -0.26 | |
Net income per share | -0.01 | 1.08 | 0.22 | 0.39 | -0.28 | |
Operating cash flow per share | 0 | -12.76 | 0.95 | 0.41 | 0.42 | |
Free cash flow per share | 0 | -12.76 | 0.95 | 0.41 | 0.42 | |
Cash per share | 16.12 | 0 | 0.02 | 0 | 0.01 | |
Book value per share | 16.11 | 10.33 | 10.2 | 10.14 | 9.38 | |
Tangible book value per share | 16.11 | 10.33 | 10.2 | 10.14 | 9.38 | |
Share holders equity per share | 16.11 | 10.33 | 10.2 | 10.14 | 9.38 | |
Interest debt per share | 0 | 3.54 | 3.3 | 3.2 | 3.23 | |
Market cap | 46.49M | 85.13M | 73.72M | 77.06M | 70.45M | |
Enterprise value | -22.6M | 112.15M | 98.68M | 101.58M | 94.91M | |
P/E ratio | -1.09K | 10.05 | 43.55 | 25.59 | -32.39 | |
Price to sales ratio | -3.38K | 9.87 | 39.71 | 24.55 | -34.9 | |
POCF ratio | 0 | -0.85 | 10.09 | 24.52 | 21.66 | |
PFCF ratio | 0 | -0.85 | 10.09 | 24.52 | 21.66 | |
P/B Ratio | 0.67 | 1.05 | 0.94 | 0.98 | 0.97 | |
PTB ratio | 0.67 | 1.05 | 0.94 | 0.98 | 0.97 | |
EV to sales | 1.64K | 13.01 | 53.15 | 32.36 | -47.01 | |
Enterprise value over EBITDA | 527.48 | 13.24 | 58.29 | 33.73 | -60.49 | |
EV to operating cash flow | 0 | -1.12 | 13.5 | 32.32 | 29.18 | |
EV to free cash flow | 0 | -1.12 | 13.5 | 32.32 | 29.18 | |
Earnings yield | 0 | 0.1 | 0.02 | 0.04 | -0.03 | |
Free cash flow yield | 0 | -1.18 | 0.1 | 0.04 | 0.05 | |
Debt to equity | 0 | 0.33 | 0.32 | 0.31 | 0.34 | |
Debt to assets | 0 | 0.25 | 0.23 | 0.23 | 0.24 | |
Net debt to EBITDA | 1.61K | 3.19 | 14.74 | 8.14 | -15.59 | |
Current ratio | 0 | 0.82 | 1.01 | 0.78 | 0.27 | |
Interest coverage | 0 | 11.09 | 4.82 | 14.04 | -2.59 | |
Income quality | 0 | -11.81 | 4.32 | 1.04 | -1.5 | |
Dividend Yield | 0 | 0.05 | 0.06 | 0.04 | 0.04 | |
Payout ratio | 0 | 0.52 | 2.48 | 1.08 | -1.2 | |
Sales general and administrative to revenue | -2.11 | 0.02 | 0.09 | 0.04 | -0.08 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.9 | 15.84 | 7.11 | 9.43 | 7.69 | |
ROIC | 0 | 0.08 | 0.02 | 0.03 | -0.02 | |
Return on tangible assets | 0 | 0.08 | 0.02 | 0.03 | -0.02 | |
Graham Net | 16.11 | -3.59 | -3.4 | -3.33 | -3.61 | |
Working capital | 69.09M | -240.83K | 54.37K | -539.85K | -3.16M | |
Tangible asset value | 69.04M | 81.03M | 78.52M | 78.27M | 72.88M | |
Net current asset value | 69.04M | -27.87M | -25.15M | -25.21M | -27.77M | |
Invested capital | 0 | 0.33 | 0.32 | 0.31 | 0.34 | |
Average receivables | 0 | 534.14K | 2.51M | 2.96M | 1.54M | |
Average payables | 0 | 654.55K | 2.66M | 3.26M | 3.41M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 45.23 | 777.06 | 228.48 | -201.36 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 8.07 | 0.47 | 1.6 | -1.81 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0.1 | 0.02 | 0.04 | -0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 24.78M | 24.53M | 24.48M | 24.46M | -82.6K | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.31 | 0.31 | 0.33 | 0.34 | 0 | |
Debt to assets | 0.23 | 0.23 | 0.25 | 0.24 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.12 | 0.78 | 4.13 | 0.27 | 9.82 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 496.99K | -539.85K | 804.3K | -3.16M | 1.51M | |
Tangible asset value | 79.25M | 78.27M | 73.36M | 72.88M | 73.8M | |
Net current asset value | -24.43M | -25.21M | -23.85M | -27.77M | 1.51M | |
Invested capital | 0.31 | 0.31 | 0.33 | 0.34 | 0 | |
Average receivables | 4.38M | 3.39M | 1.49M | 1.07M | 1.35M | |
Average payables | 4.17M | 3.41M | 1.38M | 2.29M | 2.25M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
JHAA Frequently Asked Questions
What is Nuveen Corporate Income 2023 Target Term Fund stock symbol ?
Nuveen Corporate Income 2023 Target Term Fund is a US stock , located in Chicago of Il and trading under the symbol JHAA
What is Nuveen Corporate Income 2023 Target Term Fund stock quote today ?
Nuveen Corporate Income 2023 Target Term Fund stock price is $9.7041 today.
Is Nuveen Corporate Income 2023 Target Term Fund stock public?
Yes, Nuveen Corporate Income 2023 Target Term Fund is a publicly traded company.